Elevance Health Inc

Research Elevance Health Inc (ELV) on Bullrun: valuation model: 9.0% undervalued, market cap USD 84.27B, P/E 16.5, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerELV
ExchangeNYSE
CountryUnited States
SectorHealthcare
IndustryHealthcare Plans
CurrencyUSD
Valuation signal9.0% undervalued
Market capUSD 84.27B
P/E16.5
Dividend yield1.8%
Financial periodFY2025
RevenueUSD 199.13B
Revenue growth12.5%
Net incomeUSD 5.66B
Free cash flowUSD 3.17B
Gross margin89.4%

Valuation Snapshot

Bullrun's latest valuation model marks Elevance Health Inc as 9.0% undervalued; latest market cap is USD 84.27B; P/E is 16.5; dividend yield is 1.8%.

About Elevance Health Inc

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services;

Frequently asked questions

Is Elevance Health Inc overvalued or undervalued?

Bullrun's valuation model currently marks Elevance Health Inc as 9.0% undervalued.

What is Elevance Health Inc's market cap?

Elevance Health Inc's market capitalization is USD 84.27B.

What is Elevance Health Inc's P/E ratio?

Elevance Health Inc's price-to-earnings (P/E) ratio is 16.5.

Does Elevance Health Inc pay a dividend?

Elevance Health Inc has a dividend yield of 1.8%.